0000899866-16-000272.txt : 20160301 0000899866-16-000272.hdr.sgml : 20160301 20160301183405 ACCESSION NUMBER: 0000899866-16-000272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160226 FILED AS OF DATE: 20160301 DATE AS OF CHANGE: 20160301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACKAY MARTIN CENTRAL INDEX KEY: 0001414815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 161475019 MAIL ADDRESS: STREET 1: PFIZER INC ATTN CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 4 1 wf-form4_145687523366014.xml FORM 4 X0306 4 2016-02-26 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001414815 MACKAY MARTIN C/O ALEXION PHARMACEUTICALS, INC. 100 COLLEGE STREET NEW HAVEN CT 06510 0 1 0 0 EVP & Global Head of R&D Common Stock, par value $.0001 per share 2016-02-26 4 A 0 7000 0 A 47785 D Common Stock, par value $.0001 per share 2016-02-29 4 S 0 1000 138.91 D 46785 D Option to Purchase Common Stock 140.16 2016-02-26 4 A 0 31000 140.16 A 2017-02-26 2026-02-26 Common Stock, par value $.0001 per share 31000.0 31000 D Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date. This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.00 - $138.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. 25% vests on the first anniversary of the grant date and 1/16 every three months thereafter. /s/ Michael Greco, Attorney-in-Fact for Martin Mackay 2016-03-01